Recent Developments in Nanomedicine for Pediatric Cancer
Cancer is the second biggest cause of death in children in the US. With the development of chemotherapy, there has been a substantial increase in the overall survival rate in the last 30 years. However, the overall mortality rate in children with cancer remains 25%, and many survivors experience a d...
Main Authors: | Shicheng Yang, Mia Wallach, Apurva Krishna, Raushan Kurmasheva, Srinivas Sridhar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/7/1437 |
Similar Items
-
Liposomal Nanomedicine: Applications for Drug Delivery in Cancer Therapy
by: Foad Rommasi, et al.
Published: (2021-05-01) -
Nanomedicines for the Delivery of Biologics
by: John Wahlich, et al.
Published: (2019-05-01) -
Recent advancements to enhance the therapeutic efficacy of antiepileptic drugs
by: Li Fuquan, et al.
Published: (2021-12-01) -
Recent advances in nanomedicine for antimalarial drug delivery
by: Manashjit Gogoi
Published: (2017-01-01) -
Nanomedicine review: clinical developments in liposomal applications
by: Esteban Beltrán-Gracia, et al.
Published: (2019-12-01)